Medical injection-molded parts are widely used in clinical diagnosis, treatment and nursing as important supporting components of disposable medical devices. Most products are in direct contact with human blood, mucous membranes and wound tissues, so sterile performance directly determines clinical safety. Unqualified sterile products are easy to cause cross infection and inflammatory reactions, bringing hidden dangers to patients’ health. Therefore, complete sterile testing must be carried out in the production and delivery link to fully control microbial contamination risks.
Core Methods for Finished Product Sterility TestingMembrane filtration and direct inoculation are two mainstream sterile detection methods. Membrane filtration is suitable for most medical injection parts with complex structures and hidden dead corners. Under strict aseptic operation environment, the surface microorganisms of the sample are eluted with sterile buffer solution, and the eluent is filtered through a sterile filter membrane to intercept microorganisms.

After removing the interference of bacteriostatic substances by cleaning, the filter membrane is placed in special culture media for constant temperature culture. Direct inoculation is suitable for small and simple structural parts. The sample is directly put into the culture medium for cultivation and observation. All testing processes need to complete method verification in advance to ensure the accuracy and effectiveness of detection results through positive and negative control tests.
Pre-sterilization Bioburden TestingBioburden detection is a key pre-process control before product sterilization. It mainly detects the quantity of attached microorganisms on semi-finished products in the production process, and can intuitively reflect the cleanliness of production workshops, raw material quality and cleaning and disinfection effects. Controlling the initial microbial quantity within a reasonable range can reduce the load of subsequent sterilization processes, avoid incomplete sterilization caused by excessive bacteria, and realize source control of sterile quality.
Bacterial Endotoxin TestingEndotoxin detection is an essential pyrogen detection item for high-risk medical injection parts. Residual gram-negative bacteria in the production process will produce heat-resistant endotoxin, which cannot be completely removed by conventional sterilization. Once entering the human body with blood, it will cause fever and other adverse reactions. Professional testing reagents are used for quantitative detection to strictly control the endotoxin limit and ensure the biological safety of products.

Sterilization Residue and Packaging Integrity TestingAfter sterilization, it is necessary to detect harmful residues left by sterilization media to prevent chemical irritation to human tissues. As the last barrier to maintain sterile state, packaging integrity testing cannot be ignored. Sealing tightness, structural strength and barrier performance are tested to prevent microbial secondary pollution caused by packaging damage during storage and transportation.
Testing Environment and Result Judgment SpecificationsAll sterile tests must be completed in a high-standard clean and sterile environment to prevent environmental pollution from affecting the judgment results. After the constant temperature culture cycle, if the culture medium is clear and free of bacterial and fungal growth, the product is judged to be qualified. Standardized testing specifications and strict operating norms ensure the long-term stable and safe application of medical injection parts in the medical industry.
